Nutrição e Esteatose – Artigo 15

Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis ABSTRACTAim: Despite extensive ongoing research, there is scarcity of widely accepted therapeutic options for the treatment of nonalcoholic fatty liver disease (NAFLD). Probiotics are a promising treatment option for treatingNAFLD; however, their effectiveness needs to be established. Since any single randomized controlled trial (RCT) cannot establish ...

Nutrição e Esteatose – Artigo 14

Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers AbstractBackground: A high fat diet has an essential role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). This condition is characterized by hepatic fat accumulation (steatosis) and is associated with obesity, diabetes, and fibrosis or cirrhosis of the liver. Probiotics may be useful in the treatment ...

Nutrição e Esteatose – Artigo 13

Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol AbstractBackground: Recently factors in the relationship between gut microbiota, obesity, diabetes and the metabolic syndrome have been suggested in the development and progression of nonalcoholic steatohepatitis (NASH). In this sense, this work aims to evaluate the effects of probiotic supplementation on intestinal microbiota modulation, ...

Nutrição e Esteatose – Artigo 12

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy Abstract: The gut microbiota plays critical roles in development of obese-related metabolic diseases such as nonalcoholic fatty liver disease (NAFLD), type 2 diabetes(T2D), and insulin resistance(IR), highlighting the potential of gut microbiota-targeted therapies in these diseases. There are various ways that gut microbiota can be manipulated, including ...

Nutrição e Esteatose – Artigo 11

Gut-Liver Axis, Nutrition, and Non Alcoholic Fatty Liver Disease AbstractNonalcoholic fatty liver disease (NAFLD) represents a spectrum of diseases involving hepatic fat accumulation, inflammation with the potential progression to fibrosis and cirrhosis over time. NAFLD is often associated with obesity, insulin resistance, and diabetes. The interactions between the liver and the gut, the so-called ”gut-liver axis”, play a critical role ...

Nutrição e Esteatose – Artigo 10

Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field AbstractPurpose of review—Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and it has overlapping pathogenesis with diabetes and cardiovascular disease. Reviewed here are recent advances in understanding the contribution of diet and selectednutrients to NAFLD. Recent findings—To understand the effect of ...

Nutrição e Esteatose – Artigo 9

Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease1–3 ABSTRACTNonalcoholic fatty liver disease (NAFLD) can range in spectrum from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH), which ischaracterized by lipotoxicity, hepatocellular ballooning, and inflammation and can progress to cirrhosis. Weight loss is the cornerstone treatment for NAFLD and NASH. Various randomized controlled trials have ...

Nutrição e Esteatose – Artigo 8

Nonalcoholic fatty liver disease (NAFLD) prevention: role of Mediterranean diet and physical activity Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in Western countries leading to high morbidity and mortality and is strongly related to obesity (1). Indeed, metabolic syndrome and insulin resistance play a role in the pathogenesis of NAFLD, which involves intrahepatic triglyceride accumula...